Business Context and Reporting Period
This Form 8-K Current Report was filed by Recursion Pharmaceuticals, Inc. on April 15, 2024, covering events occurring on April 15 and April 16, 2024. The filing primarily addresses corporate governance changes and executive appointments.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to executive compensation for a new hire:
- Base Salary: $570,000 per year.
- Target Bonus: 50% of base salary.
- Sign-on Bonus: $500,000 (payable 60 days after start date).
- Initial Equity Grant: Aggregate value of $8,000,000 (comprising $4,000,000 in restricted stock units and $4,000,000 in stock options), vesting over four years.
Material Changes
The Board of Directors increased its size from 8 to 9 members. Najat Khan, Ph.D., was elected as a Class II Director effective April 16, 2024, with an initial term extending until the 2026 Annual Meeting of Stockholders. Concurrently, Dr. Khan was appointed as Chief Research and Development Officer and Chief Commercial Officer, effective upon commencement of her employment.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of general business risks. It notes that Dr. Khan will not receive additional compensation for her role as a director and that there are no transactions requiring disclosure under Item 404(a) of Regulation S-K. The full employment agreements are intended to be filed as exhibits to a future periodic report.
Investor Verification Checklist
- Verify the commencement date of Dr. Khan's employment to confirm the timing of the $500,000 sign-on bonus payment.
- Review the upcoming periodic report for the full text of the employment agreements referenced in Item 5.02.
- Monitor future filings for the specific vesting schedule details of the $8,000,000 equity grant.
- Check for any subsequent committee appointments for Dr. Khan, as none were assigned at the time of this filing.